Market Size

The global vaccines market size was valued at USD xx billion in 2019 and USD 74.2 billion in 2020. Overall market is estimated to reach a value of USD xx billion in 2027. The vaccines market analysis shows that it will grow with a CAGR of 15.0% over the forecast period of 2021 to 2027.

Market Driver

Global coverage of immunization has been steadily increasing, resulting in a lucrative market growth. This strategy seeks to empower routine immunization which can prevent the spread of infectious diseases through the conduct of periodic assessments of progress toward meeting national vaccination coverage target goals. Private and government organizations that are gaining traction in this field are expected to significantly boost the vertical. World Health Organization and UNICEF have published guidelines for developing a national immunization plan, dubbed the comprehensive Multi-Year Plan, for all nations worldwide. They are working on equitable access to vaccination facilities for all individuals and increasing stakeholder participation in achieving vaccination coverage targets through the design and implementation of financially viable statewide vaccination programs. Coverage of vaccinations worldwide in 2014

Market Segment Outlook

Vaccines come in a variety of forms, including attenuated, inactivated, subunit, toxoid, recombinant vector, conjugate, and DNA. As a result of multiple feature of inactivated vaccines, such as a high stability and long shelf life, the segment is expected to dominate the market. DNA vaccines are expected to grow at the fastest rate during the forecast period, owing to their high specificity and low risk of integration into the genome when compared to other traditional vaccines. Additionally, the development of improved and new vaccines for a variety of diseases is a significant factor expected to drive growth. Availability of large number of pipeline drugs is expected to fuel the Vaccine Market's growth. Vaccines in Phase III clinical trials  which has been shown to be effective in 51% of tested adults aged 60 and above, but effectiveness decreases with age. Additionally, Oklahoma Medical Research Foundation and Merck & Co., Inc. have collaborated to develop the therapeutic Alzheimer's vaccine CAD106, which is currently undergoing phase II clinical trials.

Regional Outlook

Increased government support for vaccine development and numerous company investments in research and development are the primary drivers of North America market growth. Additionally, the established healthcare infrastructure and facilities in this region play a critical role in the development of this vertical. Asia Pacific is expected to grow at the fastest rate during the forecast period, owing to a growing target population base with significant unmet clinical needs. Additionally, the rising disposable income level and growing awareness of the vaccine's benefits in emerging economies in the Asia Pacific region are expected to support market growth.

Research Methodology

Vaccines market report consists of market analysis including both primary and secondary research. Primary research comprises of the interaction between manufacturers, industry experts channel partners, and end users, while the secondary research presents an analytical interpretation of relevant published databases, which contains details like company annual reports, and financial reports, white papers, and purchased databases. For single, team and corporate user license, we will provide 15% free customization of the report. However, alternatively, if you are looking for additional data or insight related to the scope of the report, you may purchase the "Customized Research License". Please put an enquiry for the pricing details.

About Us

Market Insight Solutions is a leading market research firm which caters to a diverse portfolio of research campaigns. We are one of the fastest growing research organization led by an extensive team of individuals. Our team has individuals with more than 10 years of experience in diverse research domains. Our strategic insights aim at providing credible and practical solutions to meet the specific requirements of our clients. We offer market studies on basis of facts across cross domains.

Segments covered in the report

Vaccines Market Size and Outlook by Technology

• Conjugate vaccines
• Inactivated and subunit vaccines
• Live attenuated vaccines
• Recombinant vaccines
• Toxoid vaccines
• Others

Vaccines Market Size and Outlook by Type

• Monovalent vaccines
• Multivalent vaccines

Vaccines Market Size and Outlook by Disease Indication

• Pneumococcal disease
• DTP
• Influenza
• HPV
• Meningococcal disease
• Polio
• Rotavirus
• Hepatitis
• MMR
• Varicella
• Herpes zoster
• Other disease indications

Vaccines Market Size and Outlook by Route of Administration

• Intramuscular and subcutaneous administration
• Oral administration
• Other routes of administration

Vaccines Market Size and Outlook by Patient Type

• Pediatric patients
• Adult patients

Vaccines Market Size and Outlook by Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • France
  • Germany
  • Russia
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • New Zealand
  • Indonesia
• Central & South America
  • Brazil
  • Chile
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

Companies Profiled in this Report

• Astrazeneca
• Bavarian Nordic
• Bharat Biotech
• Biological E
• CSL Limited
• Daiichi Sankyo Company, Limited
• Emergent Biosolutions, Inc
• Glaxosmithkline PLC
• Johnson & Johnson
• Merck & Co., Inc
• Mitsubishi Tanabe Pharma Corporation
• Panacea Biotec, LTD
• Pfizer, Inc
• Sanofi Pasteur SA
• Serum Institute of India Pvt., LTD

Actionable Outcomes

Our Vaccines Market Report offers a thorough assessment of estimations and projections on the market dynamics. Further, it helps in the implementation of these results as they show tangible benefits to business stakeholders and industry entities decisions as leaders.

Strategic Planning

Every business needs to understand how their product will Service in the forthcoming years. With the current uncertainness due to the COVID-19 scenario, this analysis becomes significant to understand past disruptions and boost the preparedness for the next steps of decision. We at Market Insight Solutions are trying to break down the complex market for the business leaders through strategic insights and resilience in unpredictable situations.

Highlights of the report:

• COVID-19 impact on Vaccines market size
• Vaccines market size, drifts, drivers and opportunities
• Analyzing the regional market for the growth factors, estimated analysis and its penetration to the global market
• Vaccines market size in United States
• Understanding the dynamics of the parent market
• Prime fluctuations of the market dynamics
• Evaluation of the market opportunities
• Historical, current, and projected Vaccines market size from the standpoint of both value and volume
• Market segmentation and comprehensive analysis in the second or third level
• Reporting and evaluation of recent industry developments
• Analysis of market share and developments
• Detailed company profiling of leading companies
• Opportunities to newer markets in global and regional markets
• Analyzing the trajectory line of the business
• Analyze Vaccines market share
• Measures to consider for Vaccines market